Bio
We haven't found any bio for you yet.
Researcher Links
Loading links...
Publications by Type
Loading publications…
The last 5 uploaded publications
Putative multiple myeloma susceptibility genes identified by exome sequencing of 347 familial and early-onset cases
Maroulio Pertesi, Delphine Demangel, Abhishek Niroula, Emeline Perrial, Maria Laura Mahecha Escobar, Maxime Vallée, Christine‐Ivy Liacos, Mehmet Samur, Adam S. Sperling, Nikhil C. Munshi, Efstathios Kastritis, Meletios A Dimopoulos, James D. McKay, Ulf‐Henrik Mellqvist, Markus Hansson, Charles Dumontet, Björn Nilsson (2025). Putative multiple myeloma susceptibility genes identified by exome sequencing of 347 familial and early-onset cases. , 40(1), DOI: https://doi.org/10.1038/s41375-025-02802-4.
Article25 days agoPatient-Reported Outcomes (PROs) and Safety in Patients (Pts) With NDMM Achieving MRD Negativity and ≥CR (MRDneg) in the Phase 3 PERSEUS and CEPHEUS Trials
Jesús F. San Miguel, Saad Z. Usmani, Sonja Zweegman, Philippe Moreau, Mario Boccadoro, Meletios A Dimopoulos, Hermann Einsele, Paula Rodríguez‐Otero, Thierry Façon, J. Blake Bartlett, Thomas J. Prior, Katharine S. Gries, Yan Wang, Huiling Pei, Maria Krevvata, Diego Vieyra, Anna Sitthi-Amorn, Melissa Rowe, Robin Carson, Nikhil C. Munshi, Bruno Paiva, Pieter Sonneveld (2025). Patient-Reported Outcomes (PROs) and Safety in Patients (Pts) With NDMM Achieving MRD Negativity and ≥CR (MRDneg) in the Phase 3 PERSEUS and CEPHEUS Trials. , 25, DOI: https://doi.org/10.1016/s2152-2650(25)04013-3.
Article25 days agoPatient-Reported Outcomes (PROs) and Safety in Patients (Pts) With NDMM Achieving MRD Negativity and ≥CR (MRDneg) in the Phase 3 PERSEUS and CEPHEUS Trials
Jesús F. San Miguel, Saad Z. Usmani, Sonja Zweegman, Philippe Moreau, Mario Boccadoro, Meletios A Dimopoulos, Hermann Einsele, Paula Rodríguez‐Otero, Thierry Façon, J. Blake Bartlett, Thomas J. Prior, Katharine S. Gries, Yan Wang, Huiling Pei, Maria Krevvata, Diego Vieyra, Anna Sitthi-Amorn, Melissa Rowe, Robin Carson, Nikhil C. Munshi, Bruno Paiva, Pieter Sonneveld (2025). Patient-Reported Outcomes (PROs) and Safety in Patients (Pts) With NDMM Achieving MRD Negativity and ≥CR (MRDneg) in the Phase 3 PERSEUS and CEPHEUS Trials. , 25, DOI: https://doi.org/10.1016/s2152-2650(25)04013-3.
Article25 days agoManagement of multiple myeloma-related renal impairment: recommendations from the International Myeloma Working Group
Meletios A Dimopoulos, Giampaolo Merlini, Frank Bridoux, Nelson Leung, Joseph Mıkhael, Simon J. Harrison, Efstathios Kastritis, Laurent Garderet, Alessandro Gozzetti, Niels W.C.J. van de Donk, Katja Weisel, Ashraf Badros, Meral Beksaç, Jens Hillengaß, Mohamad Mohty, P. Joy Ho, Ioannis Ntanasis‐Stathopoulos, María‐Victoria Mateos, Paul G. Richardson, Joan Bladé, Philippe Moreau, Jesús F. San Miguel, Nikhil C. Munshi, S. Vincent Rajkumar, Brian G.M. Durie, Heinz Ludwig, Evangelos Terpos (2023). Management of multiple myeloma-related renal impairment: recommendations from the International Myeloma Working Group. , 24(7), DOI: https://doi.org/10.1016/s1470-2045(23)00223-1.
Article25 days agoManagement of multiple myeloma-related renal impairment: recommendations from the International Myeloma Working Group
Meletios A Dimopoulos, Giampaolo Merlini, Frank Bridoux, Nelson Leung, Joseph Mıkhael, Simon J. Harrison, Efstathios Kastritis, Laurent Garderet, Alessandro Gozzetti, Niels W.C.J. van de Donk, Katja Weisel, Ashraf Badros, Meral Beksaç, Jens Hillengaß, Mohamad Mohty, P. Joy Ho, Ioannis Ntanasis‐Stathopoulos, María‐Victoria Mateos, Paul G. Richardson, Joan Bladé, Philippe Moreau, Jesús F. San Miguel, Nikhil C. Munshi, S. Vincent Rajkumar, Brian G.M. Durie, Heinz Ludwig, Evangelos Terpos (2023). Management of multiple myeloma-related renal impairment: recommendations from the International Myeloma Working Group. , 24(7), DOI: https://doi.org/10.1016/s1470-2045(23)00223-1.
Article25 days ago